To read the full story, subscribe or sign in.

Good Tryp: Psilocybin trial brings pain relief for fibromyalgia

Aug. 27, 2024

All patients dosed in a phase IIa trial with Tryptamine Therapeutics Ltd.’s (Tryp) oral psilocybin (TRP-8802) trial reported an improvement in fibromyalgia pain severity, sleep, and pain interference.

BioWorld Asia Clinical Neurology/psychiatric Small molecule Asia-Pacific Australia TGA

Today's news in brief

BioWorld

BioWorld briefs for Sept. 12, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for September 13, 2024.

3D illustration of T cells fighting cancer

Highfield Biopharmaceuticals files IND in China for immunoliposome HF-50 for solid tumors

BioWorld Science

Highfield Biopharmaceuticals Inc. has filed an IND application with China’s National Medical Products Administration (NMPA) to conduct a clinical trial of HF-50,...

Private labels, slow uptake mark first year of Humira biosimilars

BioWorld

Although last year’s massive U.S. launch of Humira biosimilars captured headlines, the market adoption of those competitors has been nothing to write home about,...

Big pharma eyes China ‘at forefront of GLP-1 revolution’

BioWorld

Two leading glucagon-like peptide-1 (GLP-1) receptor agonists for obesity and type 2 diabetes – Novo Nordisk A/S’s semaglutide (Wegovy/Ozempic) and Eli Lilly and...

Upgrade your daily dose of biopharma and medtech news

Good Tryp: Psilocybin trial brings pain relief for fibromyalgia